AI is set to shake up the investment management industry, but Gene Munster says the right mix of these soft skills could help ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...
New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children ...
The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Liver transplantation has long been a life-saving intervention for individuals with end-stage liver disease. However, its ...
Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback